Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $23.2000 (-3.33%) ($23.0000 - $24.3900) on Thu. Oct. 26, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.12% (three month average) | RSI | 33 | Latest Price | $23.2000(-3.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.8% a day on average for past five trading days. | Weekly Trend | CAPR declines -6.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) ARKK(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -6.06% in a week (0% probabilities). TLT(-8%) GLD(-8%) GDX(-8%) SLV(-6%) SIL(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.06% (StdDev 12.12%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
Resistance Level | $26.12 | 5 Day Moving Average | $23(0.87%) | 10 Day Moving Average | $23.65(-1.9%) | 20 Day Moving Average | $26.12(-11.18%) | To recent high | -32.8% | To recent low | 139.2% | Market Cap | $457m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |